Understanding of this interaction can have therapeutic potential for the design of new immunomodulatory strategies, especially in chronic disease or immune deficiency patients, for whom the homeostasis between IL-2 and IL-7 might be compromised. This evidence concerns the gene IL2 and Immunodeficiency.